| Mrs Cheryl Lynn Mcgill, MS | |
|
530 S Asbury St Ste 4, Moscow, ID 83843-2243 | |
| (208) 882-2566 | |
| Not Available |
| Full Name | Mrs Cheryl Lynn Mcgill |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 530 S Asbury St Ste 4, Moscow, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285125690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (Washington) | Secondary |
| 101YM0800X | Counselor - Mental Health | (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cheryl Lynn Mcgill, MS 530 S Asbury St Ste 4, Moscow, ID 83843-2243 Ph: (208) 882-2566 | Mrs Cheryl Lynn Mcgill, MS 530 S Asbury St Ste 4, Moscow, ID 83843-2243 Ph: (208) 882-2566 |
News Archive
As part of the University of Leicester's 50th Anniversary celebrations, a world leader in eye disorders is to give a talk on 'Dancing Eyes' on Monday 30th June 2008 at 5.30pm.
Cancer causing high-risk human papillomaviruses (HR-HPV) are responsible for the rising incidence of HR-HPV–driven head and neck cancers (HNC), particularly oropharyngeal cancers (OPC, or throat cancers). Investigators have determined that HR-HPV DNA can be detected in saliva in most patients with HPV-driven OPC at the time of diagnosis. This work highlights a potentially life-saving screening program based on salivary HR-HPV DNA testing for early cancer detection and patient monitoring. Their findings appear in The Journal of Molecular Diagnostics, published by Elsevier.
Vorys' fifth and newest blog was launched to provide interesting and pertinent analysis of a variety of issues involving health information technology (HIT). The blog, available at www.healtHITechlaw.com, will provide readers with frequent updates on developments in HIT, including HIPAA/HITECH compliance and the interplay of state privacy laws, electronic health record implementation and use challenges, review of new HIT tools and status of health information exchanges.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
› Verified 4 days ago
Monty D Hays, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 S Almon St Apt 214, Moscow, ID 83843 Phone: 208-878-2350 | |
Hannah Claire Dejong, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 316 S Jefferson St, Moscow, ID 83843 Phone: 208-883-1144 | |
Tina M Overstreet, SUDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St Ste 120, Moscow, ID 83843 Phone: 509-444-8200 | |
Christine Meyer, M.S., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2320 E F St, Moscow, ID 83843 Phone: 208-310-1549 | |
Ms. Andrea L Masom, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 106 E 3rd St, Suite 2b, Moscow, ID 83843 Phone: 208-882-1289 Fax: 208-882-8406 | |
Sophia Tsai Malmquist, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 530 S Asbury St Ste 2, Moscow, ID 83843 Phone: 208-882-2566 | |
Keith James Davis, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 805 N Main St Ste 109, Moscow, ID 83843 Phone: 208-831-7094 Fax: 208-418-9816 |